(R)-2-(Methoxymethyl)morpholine hydrochloride, 95.0%, 5g

Ethyl 1-cyanomethyl-iso-nipecotate, 95.0%, 10g

(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, 99.0%, 50mg

6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide, >95%, 50mg

Solvent red 196, BR, 25g

2,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96%, 250mg

2-Bromo-9H-xanthen-9-one, 95.0%, 100g

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(tert-butylthio)-D-cysteine, 95+%, 10g

6-CHLORO-3-HYDRAZINYL-4-PYRIDAZINECARBOXYLIC ACID, 95.0%, 250mg

2-((tert-Butoxycarbonyl)amino)-3-hydroxy-3-methylbutanoic acid, 97.0%, 1g

8-Methylimidazo[1,2-a]pyridine-2-carbaldehyde, 95.0%, 1g

Monomethyl 5-Nitroisophthalate>98.0%(GC)(T)25g

5-Amino-3-methyl-1-quinolin-5-yl-1H-pyrazole-4-carbonitrile, 95.0%, 1g